CLINICAL_TRIALS
trial_result
· 2011-02-02
Clinical Trial Update: SPC2996 in Chronic Lymphocytic Leukaemia [Phase 1, Phase 2]
Summary
Clinical trial update reporting completion of a Phase 1/2 study of SPC2996 in chronic lymphocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santaris Pharma A/S | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED